BackCarl Zeiss Meditec AG Overview

Carl Zeiss Meditec AG Receivables

Carl Zeiss Meditec AG's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Carl Zeiss Meditec AG Receivables History

Loading

Carl Zeiss Meditec AG vs. peers: Receivables Comparison

Loading

Carl Zeiss Meditec AG Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Carl Zeiss Meditec AG (AFX.DE) FAQ

The latest receivables for AFX.DE is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Carl Zeiss Meditec AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, AFX.DE's receivables moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Carl Zeiss Meditec AG's operating scale or balance-sheet position.

A receivables figure of $0 for AFX.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AFX.DE's receivables ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.